Skip to main content

Dr. Constance C. Blunt, M.D.

Medical Oncology (Medical Oncology Physician)

4950 Essen Ln Ste 500
Baton Rouge, LA 70809

Who else practices at this address →

East Baton Rouge Parish includes primary care (46% of residents) shortage areas. About shortage areas

Call (225) 757-0343

  • Medicare participating

At a glance

Years since graduation
14
In the NPI registry since
2012
Medicare patients seen, 2024
200

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2012Medical school: Texas A & M University System, Hsc, College of Medicine
  • 2012Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Medical Oncology Physician primary
    LA license 207962
  • Internal Medicine Physician
    TX license BP10043536

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Medical Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
200
Services billed
16,518
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 40-54 minutes19259
Established patient office or other outpatient visit, 30-39 minutes4835
Injection of drug or substance under skin or into muscle2011
New patient office or other outpatient visit, 60-74 minutes1414

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 19 companies reported 48 payments worth $983 in total to this clinician.

By company
Pfizer Inc.$217
Daiichi Sankyo Inc.$108
Array Biopharma Inc$97.57
AstraZeneca Pharmaceuticals LP$94.26
Novartis Pharmaceuticals Corporation$74.51
Stemline Therapeutics Inc.$43.26
Tersera Therapeutics LLC$39.50
AbbVie Inc.$37.61
By type
Food and Beverage$940
Education$43.25

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Nov 25, 2025AstraZeneca Pharmaceuticals LP
Nov 25, 2025
Education
ENHERTU · Oncology · in-kind
Company’s descriptionJournal Article
$43.25

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Louisiana →

Other Medical Oncology clinicians in Baton Rouge

Sources

NPI registry (CMS NPPES, November 2026; record last updated March 7, 2023), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1710245162. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.